Connect your AI

Natera, Inc. NTRA Stock-Based Comp

Stock-Based Comp at other companies

Myriad GeneticsMYGN

$6.5M-31.6%

Labcorp HoldingsLH

$34.9M+2.3%

Quest DiagnosticsDGX

$23M+9.5%

NeoGenomicsNEO

$8.22M-32.7%

IlluminaILMN

$60M-17.8%

CareDxCDNA

$9.8M+9.8%

Other financials

Income statement

Revenue$696.6M+38.8%

Operating income-$93.5M-18.1%

Net income-$85.1M-27.1%

EPS (diluted)-$0.60-20.0%

Balance sheet

Cash & equivalents$1.1B+11.7%

Total debt$240.1M+22.7%

Total equity$1.8B+43.1%

Total assets$2.6B+50.9%

Cash flow

Operating cash flow$40.2M-9.6%

CapEx$22.1M+1.5%

Free cash flow$18.0M-20.3%

Valuation

Market cap$36.12B+94.7%

Enterprise value$35.27B+98.8%

P/S14.4×+5.0×

Profitability

Gross margin42.9%—

Operating margin-13%+0.6pp

Net margin-14.6%+0.6pp

FCF margin4.2%-0.5pp

Returns & leverage

Return on equity-29%+4.1pp

Debt / equity0.1×0.0×

Current ratio3×-0.9×

Where this comes from

Reported directly by Natera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Natera, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Natera, Inc.'s stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Natera, Inc.'s stock-based comp?: Natera, Inc. (NTRA) reported stock-based comp of $95.11M in Q1 2026.
How has Natera, Inc.'s stock-based comp changed year-over-year?: Natera, Inc.'s stock-based comp increased by 22.2% year-over-year, from $77.83M to $95.11M.
What is the long-term trend for Natera, Inc.'s stock-based comp?: Over 4 years (2021 to 2025), Natera, Inc.'s stock-based comp has grown at a 32.4% compound annual growth rate (CAGR), from $115.22M to $354.4M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.